Skip to main content
Top
Published in: Diabetologia 7/2007

01-07-2007 | Article

Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness

Authors: G. Li, Y. Zhang, K. Y. Cheng, P. J. Scarpace

Published in: Diabetologia | Issue 7/2007

Login to get access

Abstract

Aims/hypothesis

Central pro-opiomelanocortin (Pomc) gene therapy ameliorates genetic- or age-related obesity. We hypothesised that this treatment would delay or prevent dietary obesity in young, lean rats.

Materials and methods

Recombinant adeno-associated virus encoding Pomc (rAAV-Pomc) was delivered bilaterally into the basomedial hypothalamus of lean rats for 42 days. Food intake, body weight, serum hormones, brown adipose tissue (BAT) uncoupling protein 1 (UCP1) and mRNA levels of hypothalamic neuropeptides and melanocortin receptors were assessed. Beginning on day 43, half of the rats remained on chow while the others received a high-fat diet for 89 days. We examined energy balance and responsiveness to the melanocortin agonist melanotan II (MTII) or the antagonist SHU9119.

Results

Pomc gene delivery produced elevated hypothalamic Pomc mRNA (fourfold) and α-melanocyte-stimulating hormone levels in the arcuate nucleus (twofold). Food intake and body weight were not altered by rAAV-Pomc in rats fed standard-chow. In rAAV-Pomc rats at day 42, perirenal fat and serum leptin decreased but overall visceral adiposity did not; expression of the hypothalamic agouti-related protein (Agrp) mRNA was elevated, whereas expression of melanocortin 3 and 4 receptor mRNA was reduced; BAT UCP1 protein increased nearly fourfold. The rAAV-Pomc rats fed the high-fat diet consumed more energy and gained more body weight compared with chow- or high-fat-fed controls that did not receive Pomc gene delivery. The anorexic response to MTII was impaired, whereas the orexigenic effect of SHU9119 was enhanced by rAAV-Pomc pretreatment.

Conclusions/interpretation

Delivery of the Pomc gene alters energy homeostasis in lean rats, predisposing them to diet-induced obesity. Diminished hypothalamic melanocortin receptors, increased Agrp expression, and potential rewiring of brain circuits may underlie the exacerbated obesity.
Literature
1.
go back to reference Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165–168CrossRefPubMed Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165–168CrossRefPubMed
2.
go back to reference Huszar D, Lynch CA, Fairchild-Huntress V et al (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131–141CrossRefPubMed Huszar D, Lynch CA, Fairchild-Huntress V et al (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131–141CrossRefPubMed
3.
go back to reference Mizuno TM, Mobbs CV (1999) Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140:814–817CrossRefPubMed Mizuno TM, Mobbs CV (1999) Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140:814–817CrossRefPubMed
4.
go back to reference Cone RD (1999) The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 10:211–216CrossRefPubMed Cone RD (1999) The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 10:211–216CrossRefPubMed
5.
go back to reference Butler AA, Kesterson RA, Khong K et al (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518–3521CrossRefPubMed Butler AA, Kesterson RA, Khong K et al (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518–3521CrossRefPubMed
6.
go back to reference Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L (2001) Central melanocortin receptors regulate insulin action. J Clin Invest 108:1079–1085CrossRefPubMed Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L (2001) Central melanocortin receptors regulate insulin action. J Clin Invest 108:1079–1085CrossRefPubMed
7.
8.
go back to reference Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066–1070CrossRefPubMed Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066–1070CrossRefPubMed
9.
go back to reference Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155–157CrossRefPubMed Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155–157CrossRefPubMed
10.
go back to reference Chen AS, Marsh DJ, Trumbauer ME et al (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97–102CrossRefPubMed Chen AS, Marsh DJ, Trumbauer ME et al (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97–102CrossRefPubMed
11.
go back to reference Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314CrossRefPubMed Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314CrossRefPubMed
12.
go back to reference El Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827–1832PubMed El Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827–1832PubMed
13.
go back to reference Burguera B, Couce ME, Curran GL et al (2000) Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 49:1219–1223CrossRefPubMed Burguera B, Couce ME, Curran GL et al (2000) Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 49:1219–1223CrossRefPubMed
14.
go back to reference Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG (1996) Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101–1106PubMedCrossRef Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG (1996) Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101–1106PubMedCrossRef
15.
go back to reference Schwartz MW, Seeley RJ, Woods SC et al (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119–2123CrossRefPubMed Schwartz MW, Seeley RJ, Woods SC et al (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119–2123CrossRefPubMed
16.
go back to reference Cheung CC, Clifton DK, Steiner RA (1997) Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489–4492CrossRefPubMed Cheung CC, Clifton DK, Steiner RA (1997) Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489–4492CrossRefPubMed
17.
go back to reference Baskin DG, Hahn TM, Schwartz MW (1999) Leptin sensitive neurons in the hypothalamus. Horm Metab Res 31:345–350cPubMedCrossRef Baskin DG, Hahn TM, Schwartz MW (1999) Leptin sensitive neurons in the hypothalamus. Horm Metab Res 31:345–350cPubMedCrossRef
18.
go back to reference Elias CF, Kelly JF, Lee CE et al (2000) Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423:261–281CrossRefPubMed Elias CF, Kelly JF, Lee CE et al (2000) Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423:261–281CrossRefPubMed
19.
go back to reference Scarpace PJ, Matheny M, Zhang Y et al (2002) Central leptin gene delivery evokes persistent leptin signal transduction in young and aged-obese rats but physiological responses become attenuated over time in aged-obese rats. Neuropharmacology 42:548–561CrossRefPubMed Scarpace PJ, Matheny M, Zhang Y et al (2002) Central leptin gene delivery evokes persistent leptin signal transduction in young and aged-obese rats but physiological responses become attenuated over time in aged-obese rats. Neuropharmacology 42:548–561CrossRefPubMed
20.
go back to reference Wilsey J, Zolotukhin S, Prima V, Scarpace PJ (2003) Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 285:R1011–R1020PubMed Wilsey J, Zolotukhin S, Prima V, Scarpace PJ (2003) Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 285:R1011–R1020PubMed
21.
go back to reference Hansen MJ, Ball MJ, Morris MJ (2001) Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892:130–137CrossRefPubMed Hansen MJ, Ball MJ, Morris MJ (2001) Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892:130–137CrossRefPubMed
22.
go back to reference Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS (2002) Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51:1337–1345CrossRefPubMed Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS (2002) Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51:1337–1345CrossRefPubMed
23.
go back to reference Zhang Y, Matheny M, Tumer N, Scarpace PJ (2004) Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance. Neurobiol Aging 25:1349–1360CrossRefPubMed Zhang Y, Matheny M, Tumer N, Scarpace PJ (2004) Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance. Neurobiol Aging 25:1349–1360CrossRefPubMed
24.
go back to reference Li G, Zhang Y, Wilsey JT, Scarpace PJ (2004) Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression. J Endocrinol 182:123–132CrossRefPubMed Li G, Zhang Y, Wilsey JT, Scarpace PJ (2004) Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression. J Endocrinol 182:123–132CrossRefPubMed
25.
go back to reference Bluher S, Ziotopoulou M, Bullen JW Jr et al (2004) Responsiveness to peripherally administered melanocortins in lean and obese mice. Diabetes 53:82–90CrossRefPubMed Bluher S, Ziotopoulou M, Bullen JW Jr et al (2004) Responsiveness to peripherally administered melanocortins in lean and obese mice. Diabetes 53:82–90CrossRefPubMed
26.
go back to reference Li G, Mobbs CV, Scarpace PJ (2003) Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. Diabetes 52:1951–1957CrossRefPubMed Li G, Mobbs CV, Scarpace PJ (2003) Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. Diabetes 52:1951–1957CrossRefPubMed
27.
go back to reference Li G, Zhang Y, Wilsey JT, Scarpace PJ (2005) Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats. Diabetologia 48:2376–2385CrossRefPubMed Li G, Zhang Y, Wilsey JT, Scarpace PJ (2005) Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats. Diabetologia 48:2376–2385CrossRefPubMed
28.
go back to reference Uhler M, Herbert E (1983) Complete amino acid sequence of mouse pro-opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J Biol Chem 258:257–261PubMed Uhler M, Herbert E (1983) Complete amino acid sequence of mouse pro-opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J Biol Chem 258:257–261PubMed
29.
go back to reference Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359CrossRefPubMed Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359CrossRefPubMed
30.
go back to reference Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL (2003) Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52:232–238CrossRefPubMed Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL (2003) Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52:232–238CrossRefPubMed
31.
go back to reference Mizuno TM, Kelley KA, Pasinetti GM, Roberts JL, Mobbs CV (2003) Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes 52:2675–2683CrossRefPubMed Mizuno TM, Kelley KA, Pasinetti GM, Roberts JL, Mobbs CV (2003) Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes 52:2675–2683CrossRefPubMed
32.
go back to reference Savontaus E, Breen TL, Kim A, Yang LM, Chua SC Jr, Wardlaw SL (2004) Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice. Endocrinology 145:3881–3891CrossRefPubMed Savontaus E, Breen TL, Kim A, Yang LM, Chua SC Jr, Wardlaw SL (2004) Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice. Endocrinology 145:3881–3891CrossRefPubMed
33.
go back to reference Shinyama H, Masuzaki H, Fang H, Flier JS (2003) Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144:1301–1314CrossRefPubMed Shinyama H, Masuzaki H, Fang H, Flier JS (2003) Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144:1301–1314CrossRefPubMed
34.
go back to reference de Pedro N, Delgado MJ, Alonso-Bedate M (1995) Central administration of beta-endorphin increases food intake in goldfish: pretreatment with the opioid antagonist naloxone. Regul Pept 55:189–195CrossRefPubMed de Pedro N, Delgado MJ, Alonso-Bedate M (1995) Central administration of beta-endorphin increases food intake in goldfish: pretreatment with the opioid antagonist naloxone. Regul Pept 55:189–195CrossRefPubMed
35.
go back to reference Low MJ, Hayward MD, Appleyard SM, Rubinstein M (2003) State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin. Ann N Y Acad Sci 994:192–201PubMedCrossRef Low MJ, Hayward MD, Appleyard SM, Rubinstein M (2003) State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin. Ann N Y Acad Sci 994:192–201PubMedCrossRef
36.
go back to reference Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL (1999) Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33:542–547PubMed Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL (1999) Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33:542–547PubMed
37.
go back to reference Cettour-Rose P, Rohner-Jeanrenaud F (2002) The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143:2277–2283CrossRefPubMed Cettour-Rose P, Rohner-Jeanrenaud F (2002) The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143:2277–2283CrossRefPubMed
38.
go back to reference Williams DL, Bowers RR, Bartness TJ, Kaplan JM, Grill HJ (2003) Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. Endocrinology 144:4692–4697CrossRefPubMed Williams DL, Bowers RR, Bartness TJ, Kaplan JM, Grill HJ (2003) Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. Endocrinology 144:4692–4697CrossRefPubMed
39.
go back to reference Scarpace PJ, Matheny M, Tumer N, Cheng KY, Zhang Y (2005) Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats. Diabetologia 48:1075–1083CrossRefPubMed Scarpace PJ, Matheny M, Tumer N, Cheng KY, Zhang Y (2005) Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats. Diabetologia 48:1075–1083CrossRefPubMed
40.
go back to reference Zhang J, Matheny MK, Tumer N, Mitchell MK, Scarpace PJ (2007) Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food following high-fat feeding are leptin dependent. Am J Physiol Regul Integr Comp Physiol 292:R868–R874PubMed Zhang J, Matheny MK, Tumer N, Mitchell MK, Scarpace PJ (2007) Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food following high-fat feeding are leptin dependent. Am J Physiol Regul Integr Comp Physiol 292:R868–R874PubMed
41.
42.
go back to reference Horvath TL, Naftolin F, Kalra SP, Leranth C (1992) Neuropeptide-Y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. Endocrinology 131:2461–2467CrossRefPubMed Horvath TL, Naftolin F, Kalra SP, Leranth C (1992) Neuropeptide-Y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. Endocrinology 131:2461–2467CrossRefPubMed
43.
go back to reference Cowley MA, Smart JL, Rubinstein M et al (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480–484CrossRefPubMed Cowley MA, Smart JL, Rubinstein M et al (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480–484CrossRefPubMed
Metadata
Title
Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness
Authors
G. Li
Y. Zhang
K. Y. Cheng
P. J. Scarpace
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0685-1

Other articles of this Issue 7/2007

Diabetologia 7/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.